<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Early Muscle Loss Markers on Intermuscula</title><link>https://intermuscula.com/tags/early-muscle-loss-markers/</link><description>Recent content in Early Muscle Loss Markers on Intermuscula</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Tue, 10 Feb 2026 00:00:00 +0000</lastBuildDate><atom:link href="https://intermuscula.com/tags/early-muscle-loss-markers/feed.xml" rel="self" type="application/rss+xml"/><item><title>The Role of Biomarkers in Early Sarcopenia Detection: What the Future Holds</title><link>https://intermuscula.com/blog/the-role-of-biomarkers-in-early-sarcopenia-detection-what-th/</link><pubDate>Tue, 10 Feb 2026 00:00:00 +0000</pubDate><guid>https://intermuscula.com/blog/the-role-of-biomarkers-in-early-sarcopenia-detection-what-th/</guid><description>&lt;p&gt;Sarcopenia, the progressive loss of muscle mass, strength, and function with aging, represents a significant challenge to public health. Its impact extends beyond physical limitations, contributing to falls, frailty, increased hospitalization rates, and a diminished quality of life. Current diagnostic methods often rely on physical performance tests and imaging techniques, which, while effective, can sometimes identify sarcopenia at a stage where intervention is more complex. This is where the concept of biomarkers for sarcopenia detection becomes crucial. Biomarkers, in this context, are measurable indicators of a biological state, and their potential to flag early muscle loss and dysfunction before clinical symptoms become pronounced holds significant promise for more timely and effective interventions.&lt;/p&gt;</description></item></channel></rss>